Bioprosthetic tissue with reduced calcification
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61F-002/24
A61L-027/36
A61L-027/50
A61F-002/00
출원번호
US-0138123
(2016-04-25)
등록번호
US-10188511
(2019-01-29)
발명자
/ 주소
Dove, Jeffrey S.
Dobler, Darin P.
Davidson, James A.
Wright, Gregory A.
출원인 / 주소
Edwards Lifesciences Corporation
대리인 / 주소
Sheppard Mullin
인용정보
피인용 횟수 :
0인용 특허 :
247
초록▼
A treatment for bioprosthetic tissue used in implants or for assembled bioprosthetic heart valves to reduce in vivo calcification. The method includes applying a calcification mitigant such as a capping agent or an antioxidant to the tissue to specifically inhibit oxidation in tissue. Also, the meth
A treatment for bioprosthetic tissue used in implants or for assembled bioprosthetic heart valves to reduce in vivo calcification. The method includes applying a calcification mitigant such as a capping agent or an antioxidant to the tissue to specifically inhibit oxidation in tissue. Also, the method can be used to inhibit oxidation in dehydrated tissue. The capping agent suppresses the formation of binding sites in the tissue that are exposed or generated by the oxidation and otherwise would, upon implant, attract calcium, phosphate, immunogenic factors, or other precursors to calcification. In one method, tissue leaflets in assembled bioprosthetic heart valves are pretreated with an aldehyde capping agent prior to dehydration and sterilization.
대표청구항▼
1. A packaged bioprosthetic device comprising: an at least partially cross-linked pericardial tissue comprising functional groups that have been blocked, removed or altered by reacting the functional groups with capping agents, wherein the functional groups are one or both of aldehyde groups and car
1. A packaged bioprosthetic device comprising: an at least partially cross-linked pericardial tissue comprising functional groups that have been blocked, removed or altered by reacting the functional groups with capping agents, wherein the functional groups are one or both of aldehyde groups and carboxylic acid groups; anda packaging storing the at least partially cross-linked biological tissue without a liquid preservative solution. 2. The packaged bioprosthetic device of claim 1, wherein the bioprosthetic device is a bioprosthetic heart valve comprising a stent coupled to leaflets made from the at least partially cross-linked biological tissue. 3. The packaged bioprosthetic device of claim 1, wherein the biological tissue is at least partially cross-linked with glutaraldehyde or other aldehyde-containing agents. 4. The packaged bioprosthetic device of claim 1, wherein the at least a portion of the functional groups are blocked, removed or altered by exposing the at least partially cross-linked biological tissue to a reducing agent. 5. The packaged bioprosthetic device of claim 1, wherein the at least partially cross-linked biological tissue comprises glycerol. 6. The packaged bioprosthetic device of claim 5, wherein the at least partially cross-linked biological tissue and the packaging is sterilized by ethylene oxide, gamma irradiation or electron beam irradiation. 7. The packaged bioprosthetic device of claim 1, wherein the at least partially cross-linked biological tissue is at least partially dehydrated. 8. The packaged bioprosthetic device of claim 7, wherein the at least partially cross-linked biological tissue and the packaging is sterilized by ethylene oxide, gamma irradiation or electron beam irradiation. 9. The packaged bioprosthetic device of claim 1, wherein the capping agent is one or more selected from the group consisting of: an amine, an alkyl amine, an amino alcohol, an ethanolamine, an amino acid, a lysine, a hydroxylysine, an amino sulfonate, a taurine, an amino sulfate, a dextran sulfate, a chondroitin sulfate, a hydrophilic multifunctional polymer, a polyvinyl alcohol, a polyethyleneimine, a hydrophobic multifunctional polymer, an α-dicarbonyl, a methylglyoxal, a 3-deoxyglucose, a glyoxal, a hydrazide, an adipic hydrazide, a heparin, a mono-epoxy alkane, a di-epoxy alkane, and a polyepoxyalkane. 10. The packaged bioprosthetic device of claim 9, wherein the functional groups have been reacted with a reducing agent. 11. The packaged bioprosthetic device of claim 10, wherein the reducing agent is selected from the group consisting of: a sodium borohydride and a sodium cyanoborohydride. 12. The packaged bioprosthetic device of claim 11, wherein the bioprosthetic tissue comprises glycerol. 13. The packaged bioprosthetic device of claim 1, wherein the biological tissue is at least partially cross-linked with glutaraldehyde or an aldehyde-containing agent. 14. The packaged bioprosthetic device of claim 1, wherein the capping agent is one or more selected from the group consisting of: an amine, an alkyl amine, an amino alcohol, an ethanolamine, an amino acid, a lysine, a hydroxylysine, an amino sulfonate, a taurine, an amino sulfate, a dextran sulfate, a chondroitin sulfate, a hydrophilic multifunctional polymer, a polyvinyl alcohol, a polyethyleneimine, a hydrophobic multifunctional polymer, an α-dicarbonyl, a methylglyoxal, a 3-deoxyglucose, a glyoxal, a hydrazide, an adipic hydrazide, a heparin, a mono-epoxy alkane, a di-epoxy alkane, and a polyepoxyalkane. 15. The packaged bioprosthetic device of claim 1, wherein the functional groups have been reacted with a reducing agent. 16. The packaged bioprosthetic device of claim 15, wherein the reducing agent is selected from the group consisting of: a sodium borohydride and a sodium cyanoborohydride. 17. The packaged bioprosthetic device of claim 16, wherein the bioprosthetic tissue comprises glycerol.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (247)
Stoltz,Richard; Delfyett,Peter J., Ablative material removal with a preset removal rate or volume or depth.
Badejo, Ibraheem T.; Ayarza, Jaime; Voiers, Anthony; Thompson, Jr., Roy F.; Szabo, Gabriel N.; Toni, Robert V.; Nicholson, William S. C., Antioxidant enriched adhesive compositions and storage containers therefor.
Pietsch Hanns (Hamburg DEX) Kartheus Holger (Hamburg DEX) Holtzmann Hans-Joachim (Hamburg DEX) Sachau Gnther (Quickborn DEX) Reul Helmut (Dren DEX), Antithrombogenic, non-calcifying material and method of making articles for medical purposes.
Pietsch Hanns (Hamburg DEX) Kartheus Holger (Hamburg DEX) Holtzmann Hans-Joachim (Hamburg DEX) Sachau Gnther (Quickborn DEX) Reul Helmut (Dren DEX), Antithrombogenic, non-calcifying material and method of making articles for medical purposes.
Carpentier Sophie,FRX ; Carpentier Alain F.,FRX ; Quintero Lillian J. ; Packham Victor S. ; Wang Jong H. ; Schreck Stefan G., Apparatuses for treating biological tissue to mitigate calcification.
Kim Young Ha (Seoul KRX) Park Ki Dong (Seoul KRX) Han Dong Keun (Seoul KRX) Kim Hack Joo (Seoul KRX), Bioprosthetic heart valves having high calcification resistance.
Levy Robert J. (Ann Arbor MI) Sintov Amnon (Jerusalem ILX), Calcification-resistant materials and methods of making same through use of multivalent cations.
Levy Robert J. (Ann Arbor MI) Sintov Amnon (Omer ILX), Calcification-resistant materials and methods of making same through use of multivalent cations.
Levy Robert J. (Ann Arbor MI) Sintov Amnon (Ann Arbor MI), Calcification-resistant materials and methods of making same through use of trivalent aluminum.
Abraham Ginger A. ; Carr ; Jr. Robert M. ; Kemp Paul D.,GBX ; Mercer Ryan ; Baker Linda, Chemical treatment, without detergents or enzymes, of tissue to form an acellular, collagenous matrix.
Heyninck-Jantz, Christine; Taitague, Debra; McNatt, Tomas R., Composite heart valve apparatus manufactured using techniques involving laser machining of tissue.
Linner John G. (Woodlands TX) Livesey Stephen A. (Woodlands TX) Piunno Carmen (Woodlands TX) Zaltsberg Mark (Woodlands TX) Gibson Frank (Spring TX), Cryo-slammer.
Keogh James R. (1201 Frank Ct. Maplewood MN 55109) Pearson David A. (7717 Beard Ave. North Brooklyn Park MN 55443) Eaton John W. (76 Bulson Rd. Troy NY 12180), Fixed tissue medical devices comprising albumin-binding dyes.
Oliver Roy F. (The University of Dundee ; Department of Biological Sciences ; The University Dundee DD1 4HN GB3) Grant Roy A. (Willow Wood ; 24 Harbour View Road Parkstone ; Dorset BH14 OPE GB3), Implant tissue.
Carpentier Alain (Paris FRX) Carpentier Sophie (Paris CA FRX) Nashef Aws S. (Costa Mesa CA), Implantable biological tissue and process for preparation thereof.
Carpentier Alain (Paris FRX) Carpentier Sophie (Paris CA FRX) Nashef Aws S. (Costa Mesa CA), Implantable biological tissue and process for preparation thereof.
McNally Robert T. (Marietta GA) McCaa Cameron (Marietta GA) Brockbank Kelvin G. M. (Marietta GA) Heacox Albert E. (Marietta GA) Bank Harvey L. (Charleston SC), Kit for cryopreserving blood vessels.
Ogle Matthew F. ; Holmberg William R. ; Schroeder Richard F. ; Guzik Donald S. ; Mirsch ; II M. William ; Bergman Darrin J. ; Finucane Hallie A. ; Tweden Katherine S., Medical article with adhered antimicrobial metal.
Piunno Carmen (The Woodlands TX) Livesey Stephen (Victoria TX AUX) Linner John G. (The Woodlands TX) del Campo Anthony A. (Houston TX) Zaltzberg Mark J. (The Woodlands TX), Method and apparatus for cryopreparing biological tissue.
Davis Dale R. (Poway CA) Klein Michael (La Mesa CA) de Larra Carcedo Carlos Miranda (Barcelona ESX) Mueller Bruce (Escondido CA) Martinez Ramon-Bartolome Pastor (Barcelona ESX) Raychoudhury Rana (Bar, Method for alleviating marangoni flow-induced print defects in ink-jet printing.
Carpentier, Alain F.; Carpentier, Sophie; Cunanan, Crystal M.; Quintero, Lillian; Helmus, Michael N.; Loshbaugh, Christine; Sarner, H. Chris, Method for fixation of biological tissues having mitigated propensity for post-implantation calcification and thrombosis and bioprosthetic devices prepared thereby.
Cunanan Crystal M. ; Quintero Lillian ; Helmus Michael N. ; Loshbaugh Christine ; Sarner H. Chris, Method for fixation of biological tissues having mitigated propensity for post-implantation calcification and thrombosis and bioprosthetic devices prepared thereby.
Livesey Stephen A. (Eltham TX AUX) del Campo Anthony A. (Houston TX) Nag Abhijit (Houston TX) Nichols Ken B. (The Woodlands TX) Coleman Christopher (Houston TX), Method for processing and preserving collagen-based tissues for transplantation.
Carpentier,Alain F.; Carpentier,Sophie; Cunanan,Crystal M.; Quintero,Lillian J.; Helmus,Michael N.; Loshbaugh,Christine; Sarner,H. Chris, Method for treatment of biological tissues to mitigate post-implantation calcification and thrombosis.
Jansen Josef (Mauerstr. 108 5100 Aachen DEX) Reul Helmut (Akazienstr. 65 5160 Duren DEX) Rau Gunter (Fuchserde 50 5100 Aachen DEX), Method of producing a closing member having flexible closing elements, especially a heart valve.
Carpentier Sophie,FRX ; Carpentier Alain F.,FRX ; Quintero Lillian J. ; Packham Victor S. ; Wang Jong H. ; Schreck Stefan G., Methods and apparatuses for treating biological tissue to mitigate calcification.
Arru Pietro (Turin ITX) Bona Gioacchino (Turin ITX) Curcio Maria (Saluggia ITX) Vallana Franco (Turin ITX), Methods for manufacture of valve flaps for cardiac valve prostheses.
MacPhee, Martin; Calvert, Glenn; Lynch, Tom; Kent, Randall S.; Mann, David; Burgess, Wilson; Miekka, Shirley; Drohan, William N., Methods for sterilizing biological materials by irradiation over a temperature gradient.
Carpentier, Sophie M.; Carpentier, Alain F., Methods for treating implantable biological tissues to mitigate the calcification thereof and bioprosthetic articles treated by such methods.
Colvin Stephen ; Grossi Eugene ; Katz Allan ; Oddo Paul, Passive knotless suture terminator for use in minimally invasive surgery and to facilitate standard tissue securing.
Wolfinbarger ; Jr. Lloyd, Process and composition for cleaning soft tissue grafts optionally attached to bone and soft tissue and bone grafts produced thereby.
Petite Herv (118 Avenue Saint-Exupry 69500 Bron FRX) Menasche Philippe (1 rue du Regard 75006 Paris FRX) Huc Alain (26 Chemin des Fonds 69110 Sainte Foy Les Lyon FRX), Process for crosslinking of collagen by introduction of azide groups as well as tissues and biomaterials obtained by use.
Wolfinbarger, Jr., Lloyd; Lange, Perry; Linhurst, Alyce; Moore, Eric; Nolf, Barry, Process for decellularizing soft-tissue engineered medical implants, and decellularized soft-tissue medical implants produced.
Wolfinbarger, Jr.,Lloyd; Lange,Perry; Linhurst Jones,Alyce; Moore,Eric; Nolf,Barry, Process for decellularizing soft-tissue engineered medical implants, and decellularized soft-tissue medical implants produced.
Hendriks Marc,NLX ; Michel Verhoeven,NLX ; Cahalan Patrick,NLX ; Torrianni Mark W. ; Cahalan Linda,NLX ; Fouache Benedicte,FRX, Process for making a bioprosthetic device.
Hendriks Marc,NLX ; Verhoeven Michel,NLX ; Cahalan Patrick,NLX ; Zeeman Raymond,NLX ; Dijkstra Piet,NLX ; Feijen Jan,NLX, Process for making a bioprosthetic device and implants produced therefrom.
Glowczewskie ; Jr. Frank P. (Gainesville IL) Present David A. (New York NY) Anderson David W. (New York NY) McBrayer Patrick A. (Yardley PA), Reconstitution of human bone and tissue.
Roser, Bruce J.; Colaco, Camilo; Jerrow, Mohammed A. Z.; Blair, Julian; Kampinga, Jaap; Wardell, James Lewis; Duffy, John Alistair, Solid delivery systems for controlled release of molecules incorporated therein and methods of making same.
Phillips Richard E. (San Marcos TX) Moore Mark A. (Austin TX) Russell Ruth L. (Long Beach CA) Cheung David (Arcadia CA), Sterilization of tissue implants using iodine.
Hamby, Joseph; Walsh, Steven; Heacox, Al; Goldstein, Steven; Gale, David; Arnold, Stacy; Updegrove, Ann Sands, Tissue implants for implantation and methods for preparing the same.
Neev Joseph ; Da Silva Luiz B. ; Matthews Dennis L. ; Glinsky Michael E. ; Stuart Brent C. ; Perry Michael D. ; Feit Michael D. ; Rubenchik Alexander M., Ultrashort pulse high repetition rate laser system for biological tissue processing.
Mirsch ; II M. William ; Schroeder Richard F. ; Illingworth Barbara ; Borner William H. ; Montoya Susan I., Use of microorganisms for decellularizing bioprosthetic tissue.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.